Journal
JOURNAL OF HUMAN HYPERTENSION
Volume 23, Issue 10, Pages 623-635Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/jhh.2009.21
Keywords
cancer; ACE inhibitors; Ang II antagonists
Categories
Ask authors/readers for more resources
After an early report that patients treated with angiotensin-converting enzyme (ACE) inhibitors had a lower than expected incidence of cancers, there was a large number of publications investigating the possible pathophysiological mechanism mediating this effect, as well as population studies comparing the incidence of cancers in patients treated with agents inhibiting the renin angiotensin system with their incidence in the general population. Several mechanisms are proposed to explain a potential anti-tumour activity of such agents in vitro in experimental animal models. However, the population studies are mostly inconclusive, although they do suggest a possible interaction between ACE genotypes and susceptibility to altered behaviour of certain tumours. Journal of Human Hypertension (2009) 23, 623-635; doi:10.1038/jhh.2009.21; published online 2 April 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available